Seeing Is Believing
AQST is currently covered by 5 analysts with an average price target of $10.35. This is a potential upside of $4.15 (66.94%) from yesterday's end of day stock price of $6.2.
Aquestive Therapeutics's activity chart (see below) currently has 89 price targets and 87 ratings on display. The stock rating distribution of AQST is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 17.99% with an average time for these price targets to be met of 81.63 days.
Highest price target for AQST is $10, Lowest price target is $7, average price target is $8.25.
Most recent stock forecast was given by FRANCOIS BRISEBOIS from OPPENHEIMER on 07-Sep-2025. First documented stock forecast 19-Aug-2018.
Currently out of the existing stock ratings of AQST, 13 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$8
$2.2 (37.93%)
$12
1 months 1 days ago
(07-Sep-2025)
0/3 (0%)
$2.99 (59.68%)
Buy
$10
$4.2 (72.41%)
$10
3 months 22 days ago
(16-Jun-2025)
8/30 (26.67%)
$6.65 (198.51%)
290
Buy
$7
$1.2 (20.69%)
$9
4 months 7 days ago
(01-Jun-2025)
5/7 (71.43%)
$4.19 (149.11%)
259
Buy
$8
$2.2 (37.93%)
$10
7 months 2 days ago
(06-Mar-2025)
1/8 (12.5%)
$5.35 (201.89%)
52
Buy
$9
$3.2 (55.17%)
$9
1 years 1 days ago
(07-Oct-2024)
0/10 (0%)
$4.08 (82.93%)
What is AQST (Aquestive Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?
Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?
Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?